The Risks You Don’t See: 4 Hidden Threats to Medical Device Development

By Jim Kasic, Boulder BioMed President and CEO

The decisions you make today can determine the problems you face months from now.

When a medical device development project runs into trouble, the consequences are often obvious: missed deadlines, unexpected costs, manufacturing failures or regulatory setbacks.

But the actions that caused those problems may have been made months or even years earlier. They could have stemmed from a missing design record, an incomplete transfer to manufacturing, a sterilization strategy that wasn’t considered early enough or a critical decision that fell between two vendors.

Any one of these risks can jeopardize an entire medical device development program, potentially preventing a product from ever reaching the patients who need it.

Building on an article published by Mark F. Witcher, Ph.D., Causal Mechanism and Effect Analysis (CMEA): FMEA’s Simpler, Effective Alternative, let’s explore four risks every medical device development team should be addressing. Complementing each risk, you’ll find a link to the applicable clip from our four-part video series, The Risks You Don’t See.

1. Document now, avoid risk later.
Your design history shouldn’t have to be reconstructed after the fact.

Medical device development moves quickly. Designs change, requirements evolve and decisions are made every day. Documentation doesn’t always keep pace. Months later, teams may find themselves searching through old emails, tracking down former employees and reconstructing decisions to support a regulatory submission or demonstrate compliance.

Without a reliable design history, critical decisions can become difficult to justify, putting regulatory approval and the entire development program at risk.

The takeaway: Treat documentation as part of development, not something to complete afterward.

Ask your team:

  • Who owns the design history?
  • What documentation supports the decisions we’ve made?
  • Are we documenting decisions while they’re actually being made?

2. “We sent it” Isn’t design transfer.
A design that works on the engineering bench isn’t necessarily ready for manufacturing.

Sending drawings and specifications to a manufacturer doesn’t mean design transfer is complete. A material may perform inconsistently, a process may prove difficult to repeat or a late packaging change may affect sterilization. Problems discovered during manufacturing can force significant redesign or additional validation, or even make commercial production impractical.Design transfer requires more than exchanging files. It requires documented evidence that the design has been correctly translated into specifications and processes suitable for manufacturing.

The takeaway: Establish clear ownership, acceptance criteria and a documented point of completion for design transfer.
Ask your team:
• Who owns the transfer?
• What evidence demonstrates the design is suitable for manufacturing?
• When is the transfer formally considered complete?

 

3. Early questions cost less than late answers.
The best time to explore your options is before you’ve committed to a path.

Sterilization is a good example of how early decisions shape what is possible later.

Ethylene oxide may be the right choice for a device. But relying on one sterilization modality and one facility without considering alternatives can leave a program vulnerable. Changing methods later may require substantial additional validation and regulatory work.

Early planning can also create opportunities to reduce costs. For example, gas sterilization validation requires a representative chamber load. Scientifically justified dunnage can potentially represent much of that load, reducing the amount of actual product needed and saving significant material and assembly costs. Those savings depend on making the right decisions before budgets, schedules and validation plans are finalized.

The takeaway: Involve the right experts early, when you still have the flexibility to evaluate alternatives, plan efficiently and avoid expensive changes.

Watch: Early Questions Cost Less Than Late Answers

4. Vendor handoffs carry hidden costs.
Some of the biggest risks in medical device development don’t belong to any one vendor. They exist between them.

Medical device companies often rely on different partners for design, manufacturing, packaging validation, sterilization and regulatory submissions. Each vendor may perform its work correctly, yet critical responsibilities can fall through the gaps between them.

Consider a packaging change that affects sterilization validation. If neither partner is responsible for evaluating the impact across both activities, the change may go unresolved until testing or regulatory work reveals the problem. When these gaps aren’t identified, programs can face major rework, failed validation or unresolved barriers to commercialization.

The takeaway: Manage the connections between vendors as carefully as the work each vendor performs.

For every critical handoff, ask:

  • Who owns it? Identify the person responsible for completion.
  • What document proves it? Define the evidence required.
  • When does it get locked? Establish when the decision is finalized.

Identify the Cause Before You Experience the Consequence

The common thread across these four risks is that a development program can appear to be progressing successfully while the conditions for failure are already taking shape.

Catching those conditions requires looking beyond individual tasks and deliverables to understand how decisions, processes and responsibilities affect the entire development program.

At Boulder BioMed, our integrated team brings together engineering, manufacturing, sterilization, packaging validation, and regulatory and quality expertise. Working across these disciplines helps us identify potential gaps, coordinate critical decisions and address risks before they threaten commercialization.

The risks you don’t see today could be the reason your medical device never reaches the market. Be sure to check out The Risks You Don’t See video series to learn more on how to recognize and address them earlier.

 

Back to blog home page.